Chemplast Sanmar

how big is Chemplast Sanmar?

As of Jun 06, Chemplast Sanmar Ltd has a market capitalization of 6,780.00 Cr, with recent net sales of 4,346.07 Cr and a net profit of -110.36 Cr over the last four quarters. Shareholder's funds are 1,700.58 Cr, and total assets are 6,030.30 Cr as of Mar'24.

Market Cap: As of Jun 06, Chemplast Sanmar Ltd has a market capitalization of 6,780.00 Cr, classifying it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which is consolidated data, amounts to 4,346.07 Cr. In contrast, the sum of Net Profit for the same period is -110.36 Cr.<BR><BR>Balance Sheet Snapshot: This is consolidated data for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at 1,700.58 Cr, while Total Assets stand at 6,030.30 Cr.

What does Chemplast Sanmar do?

Chemplast Sanmar Ltd is a mid-cap company in the commodity chemicals industry, incorporated in 1985, with recent quarterly net sales of ₹1,151 Cr and a net loss of ₹54 Cr. It has a market cap of ₹6,735 Cr and key metrics include a debt-equity ratio of 0.54 and a return on equity of -5.34%.

Overview:<BR>Chemplast Sanmar Ltd operates in the commodity chemicals industry and is categorized as a mid-cap company.<BR><BR>History:<BR>Incorporated in 1985, Chemplast Sanmar Ltd was initially promoted as Urethanes India by Chemplast, the flagship of the Sanmar Group, Tamil Nadu. It became a fully-owned subsidiary of Chemplast in 1991, at which point it adopted its current name. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,151 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -54 Cr (Quarterly Results - Mar 2025)<BR>- Market cap: Rs 6,735 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A (Loss Making)<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.54<BR>- Return on Equity: -5.34%<BR>- Price to Book: 3.27<BR><BR>Contact Details:<BR>Address: 9 Cathedral Road, Chennai Tamil Nadu: 600086 <BR>Tel: +91-44-28128500 <BR>Email: grd@sanmargroup.com <BR>Website: http://www.chemplastsanmar.com

Has Chemplast Sanmar declared dividend?

No Dividend History Available

Is Chemplast Sanmar overvalued or undervalued?

As of June 12, 2025, Chemplast Sanmar is considered overvalued with a PE ratio of -62.46 and an EV to EBITDA of 36.64, underperforming the Sensex with a stock return of -17.71% compared to the Sensex's 6.64%.

As of 12 June 2025, Chemplast Sanmar's valuation grade has moved from fair to expensive. The company is currently overvalued, with a PE ratio of -62.46, an EV to EBITDA ratio of 36.64, and a Price to Book Value of 3.33. These ratios indicate significant concerns regarding profitability and valuation relative to its assets.<BR><BR>In comparison to its peers, Chemplast Sanmar's valuation stands out unfavorably; for instance, Godrej Industries is rated attractive with a PE of 44.06 and an EV to EBITDA of 33.16. Additionally, Solar Industries is categorized as very expensive with a PE of 124.55 and an EV to EBITDA of 76.70. Furthermore, Chemplast Sanmar has underperformed the Sensex over the past year, with a stock return of -17.71% compared to the Sensex's 6.64%, reinforcing the notion that the stock is currently overvalued.

Who are the peers of the Chemplast Sanmar?

Chemplast Sanmar's peers include Tata Chemicals, India Glycols, GHCL, and others, with varying management risks and growth rates. Notably, India Glycols has the highest 1-year return at 99.07%, while Chemplast Sanmar has the lowest at -20.06%.

Peers: The peers of Chemplast Sanmar are Tata Chemicals, India Glycols, GHCL, Fischer Medical, Grauer & Weil, Tanfac Inds., Gujarat Alkalies, Blue Pearl Agri, Thirumalai Chem, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Fischer Medical, while Good management risk is found at Chemplast Sanmar. Average management risk is seen at Tata Chemicals, India Glycols, Grauer & Weil, Tanfac Inds., Thirumalai Chem, and J.G.Chemicals, and the rest. Below Average management risk is present at Gujarat Alkalies, while Blue Pearl Agri does not qualify. Growth is Excellent at Tanfac Inds., while Below Average growth is noted at Chemplast Sanmar, Tata Chemicals, India Glycols, GHCL, Grauer & Weil, Gujarat Alkalies, Thirumalai Chem, and J.G.Chemicals, and the rest. Average growth is observed at Fischer Medical, while Excellent capital structure is seen at GHCL, Grauer & Weil, and Tanfac Inds. Average capital structure is found at Tata Chemicals and Thirumalai Chem, while Below Average capital structure is noted at Chemplast Sanmar, India Glycols, and Gujarat Alkalies, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 99.07%, while Chemplast Sanmar has the lowest at -20.06%. This indicates that Chemplast Sanmar's return is significantly lower than that of India Glycols. Additionally, peers with a negative six-month return include Chemplast Sanmar, GHCL, Gujarat Alkalies, and Blue Pearl Agri.

Who are in the management team of Chemplast Sanmar?

As of March 2023, the management team of Chemplast Sanmar includes Vijay Sankar (Chairman), Ramkumar Shankar (Managing Director), and several independent and non-executive directors, totaling nine members. This team ensures effective governance and oversight of the company.

As of March 2023, the management team of Chemplast Sanmar includes the following individuals:<BR><BR>1. Vijay Sankar - Chairman (Non-Executive)<BR>2. Ramkumar Shankar - Managing Director<BR>3. Chandran Ratnaswami - Non-Executive & Non-Independent Director<BR>4. Lakshmi Vijayakumar - Independent Director<BR>5. Aditya Jain - Independent Director<BR>6. Sanjay Bhandarkar - Independent Director<BR>7. Prasad R Menon - Independent Director<BR>8. M Raman - Company Secretary & Compliance Officer<BR>9. Vikram Taranath Hosangady - Non-Executive Director<BR><BR>This diverse team comprises both executive and non-executive members, with various independent directors contributing to the governance of the company.

Who are the top shareholders of the Chemplast Sanmar?

The top shareholders of Chemplast Sanmar are Sanmar Holdings Limited with 54.99%, mutual funds owning 24.11%, and foreign institutional investors holding 13.27%. SBI Long Term Equity Fund is the largest public shareholder at 9.82%, while individual investors hold about 4.57%.

The top shareholders of Chemplast Sanmar include Sanmar Holdings Limited, which holds the largest stake at 54.99%. Other significant shareholders are mutual funds, which collectively own 24.11% through 12 schemes, and foreign institutional investors (FIIs) with a combined holding of 13.27% across 80 FIIs. Additionally, SBI Long Term Equity Fund is the highest public shareholder with 9.82%. Individual investors hold about 4.57% of the company.

How has been the historical performance of Chemplast Sanmar?

Chemplast Sanmar's historical performance shows a decline in net sales and profits from a peak in March 2022, with net sales dropping from 5,891.99 Cr to 4,346.07 Cr by March 2025, and profit after tax turning negative at -110.36 Cr. Despite an increase in total assets and liabilities, the company has faced significant challenges in profitability and cash flow in recent years.

Answer:<BR>The historical performance of Chemplast Sanmar shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Chemplast Sanmar's net sales peaked at 5,891.99 Cr in March 2022 but have since declined to 4,346.07 Cr in March 2025. The total operating income followed a similar pattern, reaching a high of 5,891.99 Cr in March 2022 before dropping to 4,346.07 Cr in March 2025. The company experienced significant variations in operating profit, with a high of 1,254.29 Cr in March 2022, but a decline to 265.72 Cr by March 2025. Profit before tax turned negative in March 2024 and 2025, with figures of -225.57 Cr and -169.07 Cr, respectively, after being positive in earlier years. The profit after tax also reflected this downturn, moving from a high of 648.65 Cr in March 2022 to -110.36 Cr in March 2025. Total liabilities increased from 4,107.54 Cr in March 2020 to 6,503.19 Cr in March 2025, while total assets rose from 4,107.54 Cr to 6,503.19 Cr in the same period. Cash flow from operating activities has been negative in the last two years, with -244.00 Cr in March 2024 and a further decline in March 2025. Overall, Chemplast Sanmar's financial performance indicates challenges in profitability and cash flow, despite growth in total assets and liabilities.

Is Chemplast Sanmar technically bullish or bearish?

As of December 2, 2025, Chemplast Sanmar's technical trend has shifted to a bearish stance with moderate strength, supported by bearish indicators across multiple timeframes, despite some mildly bullish signals in the monthly analysis.

As of 2 December 2025, the technical trend for Chemplast Sanmar has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this assessment include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands and KST on both weekly and monthly timeframes, and bearish moving averages on the daily chart. The Dow Theory also confirms a bearish trend across both weekly and monthly perspectives. Despite a mildly bullish monthly MACD and bullish monthly RSI, the overall technical picture remains negative, particularly in the short term.

When is the next results date for Chemplast Sanmar Ltd?

The next results date for Chemplast Sanmar Ltd is 07 February 2026.

The next results date for Chemplast Sanmar Ltd is scheduled for 07 February 2026.

Are Chemplast Sanmar Ltd latest results good or bad?

Chemplast Sanmar Ltd's latest results are concerning, showing a net loss of ₹51.04 crore despite a slight revenue increase. While there are minor improvements in operating margins, ongoing losses and a negative return on equity indicate significant financial challenges, suggesting caution for investors.

Chemplast Sanmar Ltd's latest results indicate a challenging situation for the company. In Q2 FY26, the company reported a net loss of ₹51.04 crore, which is a significant decline compared to the previous quarter's loss of ₹64.25 crore, but still reflects ongoing profitability issues. While revenue increased by 4.07% year-on-year to ₹1,033.20 crore, it saw a sequential decline of 6.06% from the previous quarter, highlighting demand challenges.<BR><BR>On a positive note, the operating margin (excluding other income) improved to 4.19% from 1.55% in the prior quarter, suggesting some operational efficiency gains. However, this margin remains far below historical levels and indicates that the company is still struggling to achieve sustainable profitability.<BR><BR>The company's financial health is further complicated by a high interest burden of ₹60.33 crore, which exceeds its operating profit, leaving little room for covering other expenses. Additionally, the return on equity (ROE) has turned negative at -5.34%, signaling a deterioration in capital efficiency.<BR><BR>Overall, while there are minor improvements in operational metrics, the persistent losses and structural challenges suggest that the latest results are not favorable for Chemplast Sanmar Ltd. Investors should approach the stock with caution, given the ongoing financial difficulties and uncertain outlook for profitability recovery.

Should I buy, sell or hold Chemplast Sanmar Ltd?

Why is Chemplast Sanmar Ltd falling/rising?

As of 08-Feb, Chemplast Sanmar Ltd's stock price is at 260.00, reflecting a slight decline and a total drop of -2.62% over the last two days. The stock has significantly underperformed over the past year with a -45.42% return, attributed to high debt levels, declining sales, and negative operating profits, despite some positive management efficiency indicators.

As of 08-Feb, Chemplast Sanmar Ltd's stock price is currently at 260.00, reflecting a slight decline of -0.2 (-0.08%). The stock has been experiencing a downward trend, having fallen for the last two consecutive days, resulting in a total decline of -2.62% during this period. This recent performance is in stark contrast to the benchmark Sensex, which has increased by +1.59% over the past week.<BR><BR>Over the longer term, the stock has shown significant underperformance, with a staggering -45.42% return over the past year compared to a +7.07% gain in the Sensex. Additionally, the stock has consistently underperformed against the benchmark over the last three years, with a -39.46% return compared to a +38.13% return for the Sensex.<BR><BR>Several factors contribute to the stock's decline. The company has a high Debt to EBITDA ratio of 4.30 times, indicating a low ability to service its debt, which raises concerns about its financial health. Furthermore, the company has reported poor long-term growth, with net sales declining at an annual rate of -3.77% and operating profit plummeting by -154.13% over the last five years. The recent financial results have also shown negative operating profits, and the stock is trading at a risky valuation compared to its historical averages.<BR><BR>Despite some positive indicators, such as high management efficiency with a return on capital employed (ROCE) of 16.72% and high institutional holdings at 38.68%, the overall outlook remains negative due to the company's financial struggles and consistent underperformance. Thus, these factors collectively explain why Chemplast Sanmar Ltd's stock price is currently falling.

Which are the latest news on Chemplast Sanmar?